171 related articles for article (PubMed ID: 32969542)
1. Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease.
Das S; Shastry S; Chakravarthy PK; Baliga PB
Transfus Med; 2021 Feb; 31(1):30-35. PubMed ID: 32969542
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the severity of ABO haemolytic disease of the newborn by cord blood tests.
Whyte J; Graham H
Acta Paediatr Scand; 1981 Mar; 70(2):217-22. PubMed ID: 7195139
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years.
Rahmati A; Farhat AS; Boroumand-Noughabi S; Soleymani F; Keramati M
Transfus Apher Sci; 2022 Jun; 61(3):103358. PubMed ID: 35074271
[TBL] [Abstract][Full Text] [Related]
4. CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.
Awad HA; Tantawy AA; El-Farrash RA; Ismail EA; Youssif NM
Blood Transfus; 2014 Apr; 12(2):250-9. PubMed ID: 24333075
[TBL] [Abstract][Full Text] [Related]
5. A study on diagnostic performance of different immunohematological diagnostic tests in assessing the prevalence of ABO Hemolytic Disease of Newborn in the antenatal O group mothers and their neonatal outcome in a tertiary care hospital in Northern India.
Deb J; Jain A; Kaur D; Bahadur A; Basu S; Negi G
Transfus Apher Sci; 2024 Feb; 63(1):103864. PubMed ID: 38135544
[TBL] [Abstract][Full Text] [Related]
6. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
Schönitzer D; Frisch H
Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
[TBL] [Abstract][Full Text] [Related]
7. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
8. Haematolytic disease due to ABO incompatibility: incidence and value of screening in an Asian population.
Han P; Kiruba R; Ong R; Joseph R; Tan KL; Wong HB
Aust Paediatr J; 1988 Feb; 24(1):35-8. PubMed ID: 3355442
[TBL] [Abstract][Full Text] [Related]
9. The Spectrum of Hemolytic Disease of the Newborn: Evaluating the Etiology of Unconjugated Hyperbilirubinemia Among Neonates Pertinent to Immunohematological Workup.
Routray SS; Behera R; Mallick B; Acharya D; Sahoo JP; Kanungo GN; Pati B
Cureus; 2021 Aug; 13(8):e16940. PubMed ID: 34513509
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers.
Talwar M; Jain A; Sharma RR; Kumar P; Saha SC; Singh L
Vox Sang; 2022 Sep; 117(9):1112-1120. PubMed ID: 35667836
[TBL] [Abstract][Full Text] [Related]
11. Importance of Direct Antiglobulin Test (DAT) in Cord Blood: Causes of DAT (+) in a Cohort Study.
Valsami S; Politou M; Boutsikou Τ; Briana D; Papatesta M; Malamitsi-Puchner A
Pediatr Neonatol; 2015 Aug; 56(4):256-60. PubMed ID: 25637293
[TBL] [Abstract][Full Text] [Related]
12. Early diagnosis of ABO haemolytic disease of the newborn.
Procianoy RS; Giacomini CB; Farina DM; Mollin GA; Winckler MI; Silveira MB; Campos L; Marques-Pereira JP
Eur J Pediatr; 1987 Jul; 146(4):390-3. PubMed ID: 3653135
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of combination detection of direct antiglobulin test and serum albumin globulin ratio in severe hyperbilirubinemia caused by ABO hemolytic disease of the newborn.
Duan L; Chen P; Tu N; Hu H
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2228965. PubMed ID: 37369373
[No Abstract] [Full Text] [Related]
14. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
Front Immunol; 2021; 12():698541. PubMed ID: 35003054
[TBL] [Abstract][Full Text] [Related]
15. ABO hemolytic disease of the newborn: a need for clarity and consistency in diagnosis.
Watchko JF
J Perinatol; 2023 Feb; 43(2):242-247. PubMed ID: 36344813
[TBL] [Abstract][Full Text] [Related]
16. What is the best predictor of the severity of ABO-haemolytic disease of the newborn?
Brouwers HA; Overbeeke MA; van Ertbruggen I; Schaasberg W; Alsbach GP; van der Heiden C; van Leeuwen EF; Stoop JW; Engelfriet CP
Lancet; 1988 Sep; 2(8612):641-4. PubMed ID: 2901516
[TBL] [Abstract][Full Text] [Related]
17. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
Ercin S; Coskun Y; Kayas K; Kavas N; Gursoy T
Am J Perinatol; 2024 Mar; 41(4):505-510. PubMed ID: 34847590
[TBL] [Abstract][Full Text] [Related]
18. [Detection and analysis of ABO Hemolytic disease in newborn].
Lin ZX; Dong QS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1432-4. PubMed ID: 25338602
[TBL] [Abstract][Full Text] [Related]
19. Morbidity of ABO haemolytic disease in the newborn.
Bhat YR; Kumar CG
Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
[TBL] [Abstract][Full Text] [Related]
20. [Investigation and Analysis of Non-ABO Hemolytic Disease of the Newborn].
Zheng YL; Hong Q; Wang QM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1330-1333. PubMed ID: 34362525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
